Increased response of renal perfusion to the antioxidant vitamin C in type 2 diabetes

Nephrology Dialysis Transplantation

Volumn 19, Issue 10, 2004, Pages 2513-2518

  Delles, Christian ^a   Schneider, Markus P ^a   Oehmer, Sebastian ^a   Fleischmann, Ingrid ^a   Fleischmann, Erwin F ^a   Schmieder, Roland E ^a  

^a UNIVERSITY OF ERLANGEN NUREMBERG   (Germany)

Author keywords

Oxidative stress; Renal perfusion; Type 2 diabetes

Indexed keywords

ANTIOXIDANT; ARGININE; ASCORBIC ACID; N(G) METHYLARGININE; NITRIC OXIDE; REACTIVE OXYGEN METABOLITE;

ADULT; AGED; ANTIOXIDANT ACTIVITY; ARTICLE; BIOAVAILABILITY; CLINICAL ARTICLE; CONTROLLED STUDY; DIABETIC NEPHROPATHY; DRUG RESPONSE; ENDOTHELIUM LESION; FEMALE; HUMAN; HYPERTENSION; KIDNEY BLOOD FLOW; KIDNEY BLOOD VESSEL; KIDNEY PERFUSION; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; OXIDATIVE STRESS; PRIORITY JOURNAL;

AGED; ANTIOXIDANTS; ARGININE; ASCORBIC ACID; CASE-CONTROL STUDIES; DIABETES MELLITUS, TYPE 2; DRUG COMBINATIONS; ENZYME INHIBITORS; FEMALE; HUMANS; HYPERTENSION; INFUSIONS, INTRAVENOUS; MALE; MIDDLE AGED; OMEGA-N-METHYLARGININE; RENAL CIRCULATION;

EID: 5444235606     PISSN: 09310509     EISSN: None     Source Type: Journal    
DOI: 10.1093/ndt/gfh405     Document Type: Article

References (24)

1. Schnackenberg CG. Oxygen radicals in cardiovascular-renal disease. Curr Opin Pharmacol 2002; 2: 121-125
2. Katusic ZS. Vascular endothelial dysfunction: does tetrahydro-biopterin play a role? Am J Physiol 2001; 281: H981-H986
3. Enderle MD, Benda N, Schmuelling RM, Haering HU, Pfohl M. Preserved endothelial function in IDDM patients, but not in NIDDM patients, compared with healthy subjects. Diabetes Care 1998; 21: 1778-1779
4. Ting HH, Timimi FK, Boles KS, Creager SJ, Ganz P, Creager MA. Vitamin C improves endothelium-dependent vasodilation in patients with non-insulin-dependent diabetes mellitus. J Clin Invest 1996; 97: 22-28
5. Perticone F, Ceravolo R, Pujia A et al. Prognostic significance of endothelial dysfunction in hypertensive patients. Circulation 2001; 104: 191-196
6. Ishii N, Patel KP, Lane PH et al. Nitric oxide synthesis and oxidative stress in the renal cortex of rats with diabetes mellitus. J Am Soc Nephrol 2001; 12: 1630-1639
7. 2 and NO. Am J Physiol 2000; 279: F302-F308
8. Schnackenberg CG, Wilcox CS. The SOD mimetic tempol restores vasodilation in afferent arterioles of experimental diabetes. Kidney Int 2001; 59: 1859-1864
9. Opara EC, Abdel-Rahman E, Soliman S et al. Depletion of total antioxidant capacity in type 2 diabetes. Metabolism 1999; 48: 1414-1417
10. Delles C, Jacobi J, Schlaich MP, John S, Schmieder RE. Assessment of endothelial function of the renal vasculature in human subjects. Am J Hypertens 2002; 15: 3-9
11. Delles C, Schmieder RE. Endothelfunktion im Nierenstromgebiet des Menschen. Disch Med Wochenschr 2003; 128: 92-96
12. Smith HW, Finkelstein N, Aliminosa L, Crawford B, Graber M. The renal clearance of substituted hippuric acid derivates and other aromatic acids in dogs and man. J Clin Invest 1945; 24: 388-398
13. Hamilton CA, Brosnan MJ, McIntyre M, Graham D, Dominiczak AF. Superoxide excess in hypertension and aging - a common cause of endothelial dysfunction. Hypertension 2001; 37: 529-534
14. John S, Jacobi J, Delles C, Schlaich MP, Schneider MP, Schmieder RE. Rapid improvement of nitric oxide bioavailability after lipid lowering therapy with cerivastatin within two weeks. J Am Coll Cardiol 2001; 37: 1351-1358
15. Delles C, Klingbeil AU, Schneider MP, Handrock R, Schaufele T, Schmieder RE. The role of nitric oxide in the regulation of glomerular haemodynamics in humans. Nephrol Dial Transplant 2004; 19: 1392-1397
16. Mayer BX, Mensik C, Krishnaswami S et al. Pharmacokinetic-pharmacodynamic profile of systemic nitric oxide-synthase inhibition with L-NMMA in humans. Br J Clin Pharmacol 1999; 47: 539-544
17. Ohishi K, Carmines PK. Superoxide dismutase restores the influence of nitric oxide on renal arterioles in diabetes mellitus. J Am Soc Nephrol 1995; 5: 1559-1566
18. Leinonen J, Rantalaiho V, Lehtimaki T et al. The association between the total antioxidant potential of plasma and the presence of coronary heart disease and renal dysfunction in patients with NIDDM. Free Radic Res 1998; 29: 273-281
19. Heitzer T, Schlinzig T, Krohn K et al. Endothelial dysfunction, oxidative stress, and risk of cardiovascular events in patients with coronary artery disease. Circulation 2001; 104: 2673-678
20. Taddei S, Virdis A, Ghiadoni L, Magagna A, Salvetti A. Vitamin C improves endothelium-dependent vasodilation by restoring nitric oxide activity in essential hypertension. Circulation 1998; 97: 2222-2229
21. Schneider MP, Klingbeil AU, Delles C, Schmidt BM, John S, Schmieder RE. Vitamin C augments the renal response to L-arginine in smokers. Nephrol Dial Transplant 2003; 18: 1512-1517
22. Veelken R, Hilgers KF, Hartner A, Haas A, Böhmer KP, Sterzel RB. Nitric oxide synthase isoforms and glomerular hyperfiltration in early diabetic nephropathy. J Am Soc Nephrol 2000; 11: 71-79
23. Dalla Vestra M, Sacerdoti D, Bombonato G et al. Nitric oxide modulation of renal and cardiac hemodynamics in type 2 diabetes. Eur J Endocrinol 2002; 146: 687-694
24. Himmelfarb J, Stenvinkel P, Ikizler TA, Hakim RM. The elephant in uremia: oxidant stress as a unifying concept of cardiovascular disease in uremia. Kidney Int 2002; 62: 1524-1538